Helen C. Adams - Net Worth and Insider Trading

Helen C. Adams Net Worth

The estimated net worth of Helen C. Adams is at least $120,760 dollars as of 2024-10-31. Helen C. Adams is the Director of Prometheus Biosciences Inc and owns about 500 shares of Prometheus Biosciences Inc (RXDX) stock worth over $99,960. Helen C. Adams is also the Director of Immix Biopharma Inc and owns about 13,000 shares of Immix Biopharma Inc (IMMX) stock worth over $20,800. Details can be seen in Helen C. Adams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Helen C. Adams has not made any transactions after 2023-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Helen C. Adams

To

Helen C. Adams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Helen C. Adams owns 4 companies in total, including Genasys Inc (GNSS) , Turtle Beach Corp (HEAR) , and Prometheus Biosciences Inc (RXDX) among others .

Click here to see the complete history of Helen C. Adams’s form 4 insider trades.

Insider Ownership Summary of Helen C. Adams

Ticker Comapny Transaction Date Type of Owner
GNSS Genasys Inc 2010-03-24 director
HEAR Turtle Beach Corp 2010-08-23 director
RXDX Prometheus Biosciences Inc 2021-03-16 director
LIMIT LIMIT 2023-09-12 director

Helen C. Adams Latest Holdings Summary

Helen C. Adams currently owns a total of 2 stocks. Among these stocks, Helen C. Adams owns 500 shares of Prometheus Biosciences Inc (RXDX) as of March 16, 2021, with a value of $99,960 and a weighting of 82.78%. Helen C. Adams also owns 13,000 shares of Immix Biopharma Inc (IMMX) as of September 12, 2023, with a value of $20,800 and a weighting of 17.22%.

Latest Holdings of Helen C. Adams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RXDX Prometheus Biosciences Inc 2021-03-16 500 199.92 99,960
IMMX Immix Biopharma Inc 2023-09-12 13,000 1.60 20,800

Holding Weightings of Helen C. Adams


Helen C. Adams Form 4 Trading Tracker

According to the SEC Form 4 filings, Helen C. Adams has made a total of 1 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prometheus Biosciences Inc is the acquisition of 500 shares on March 16, 2021, which cost Helen C. Adams around $9,500.

According to the SEC Form 4 filings, Helen C. Adams has made a total of 1 transactions in Immix Biopharma Inc (IMMX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Immix Biopharma Inc is the acquisition of 13,000 shares on September 12, 2023, which cost Helen C. Adams around $38,480.

Insider Trading History of Helen C. Adams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Helen C. Adams Trading Performance

GuruFocus tracks the stock performance after each of Helen C. Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Helen C. Adams is 41.44%. GuruFocus also compares Helen C. Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Helen C. Adams within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Helen C. Adams's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Helen C. Adams

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.96 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 13.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Helen C. Adams Ownership Network

Ownership Network List of Helen C. Adams

No Data

Ownership Network Relation of Helen C. Adams

Insider Network Chart

Helen C. Adams Owned Company Details

What does Genasys Inc do?

Who are the key executives at Genasys Inc?

Helen C. Adams is the director of Genasys Inc. Other key executives at Genasys Inc include 10 percent owner Awm Investment Company, Inc. , CEO Richard Danforth , and CFO/Secretary Dennis D Klahn .

Genasys Inc (GNSS) Insider Trades Summary

Over the past 18 months, Helen C. Adams made no insider transaction in Genasys Inc (GNSS). Other recent insider transactions involving Genasys Inc (GNSS) include a net purchase of 60,000 shares made by Osgood Richard Hoe Iii , a net purchase of 33,000 shares made by Scott L Anchin , and a net purchase of 1,400,000 shares made by Awm Investment Company, Inc. .

In summary, during the past 3 months, insiders sold 0 shares of Genasys Inc (GNSS) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 0 shares of Genasys Inc (GNSS) were sold and 1,543,000 shares were bought by its insiders, resulting in a net purchase of 1,543,000 shares.

Genasys Inc (GNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Genasys Inc Insider Transactions

No Available Data

Helen C. Adams Mailing Address

Above is the net worth, insider trading, and ownership report for Helen C. Adams. You might contact Helen C. Adams via mailing address: 15378 Avenue Of Science, Ste 100, San Diego Ca 92128.